Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2025-12-27 @ 11:32 PM
Study NCT ID:
NCT01735968
Status:
COMPLETED
Last Update Posted:
2020-12-21
First Post:
2012-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-15
First Submit QC Date:
None
Study First Post Date:
2012-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-17
Last Update Post Date:
2020-12-21
Last Update Post Date Type:
ACTUAL